Single Dose Gadobutrol in Comparison to Single Dose Gadobenate Dimeglumine for Magnetic Resonance Imaging of Chronic Myocardial Infarction at 3 Tesla (Gadovit)

NCT01655290 Phase 2 COMPLETED

This study aims at evaluating the diagnostic efficacy of Gadobutrol versus Gadobenate dimeglumine at similar dose of 0.1mmol/kg for assessment of myocardial infarction by delayed enhancement cardiac Magnetic Resonance Imaging

Details

Lead sponsor	Technical University of Munich
Phase	Phase 2
Status	COMPLETED
Enrolment	20
Start date	2012-08
Completion	2014-06

Conditions

• Subacute/Chronic Myocardial Infarction

Interventions

• Gadovist® (Gadobutrol), Multihance® (Gadobenate dimeglumin)

Primary outcomes

• Efficacy (contrast-to-noise ratio)

Countries

Germany